Article

Lung Disease Network Reveals the Impact of Comorbidity on SARS-CoV-2 Infection and Opportunities of Drug Repurposing

2020-12-10

Abstract excerpt

Higher mortality of COVID-19 patients with comorbidity is the formidable challenge faced by the health care system. In response to the present crisis, understanding the molecular basis of comorbidity is essential to accelerate the development of drugs. To address this, the genetic association between COVID-19 and various lung disorders was measured and notable molecular resemblance was observed. 141 lung diseases...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ba1ef3a8-25c3-5c46-a709-bf0e9a2d95ae
DOI: 10.21203/rs.3.rs-121999/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lung Disease Network Reveals the Impact of Comorbidity on SARS-CoV-2 Infection and Opportunities of Drug RepurposingDOI 10.21203/rs.3.rs-121999/v1Read

Lung Disease Network Reveals the Impact of Comorbidity on SARS-CoV-2 infectionSemantic proximity Read

Identification of pulmonary comorbid diseases network based repurposing effective drugs for COVID-19Semantic proximity Read

In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposingSemantic proximity Read

Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patientsSemantic proximity Read

Impact of Comorbidity on Severity of Covid-19 Patients: A Network of Target Coding Genes PerspectiveSemantic proximity Read

Uncovering the Genetic Links of SARS-CoV-2 Infections on Heart Failure Co-Morbidity by a Systems Biology ApproachSemantic proximity Read

Identification of COVID-19 and COPD common key genes and pathways using a protein-protein interaction approachSemantic proximity Read

Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications.Semantic proximity Read

Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseasesSemantic proximity Read

Molecular signatures in the progression of COVID-19 severitySemantic proximity Read

Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19Semantic proximity Read

Transcriptome and SARS-CoV-2 biological network directed analysis for better therapeutic developmentSemantic proximity Read